AzTrials
AzTrials

Communication, MultidisciplinaryNCT05986929

Acceptability, Barriers and Facilitators of a Communication Tool in Hospital Settings

An observational study of Communication, Multidisciplinary, run by Université de Sherbrooke at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The presence of appropriate systems to promote good communication within the care team is one of the ten important characteristics identified for effective interdisciplinary work. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Communication, Multidisciplinary
What is being tested?
focus group and electronic survey
How many people
41 participants
Where
1 siteCanada
Study dates
17 Jan 2024to 5 Jul 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population will consist of staff members working with people hospitalized in the neurology-stroke and geriatric units of SUH. The sample will be made up of various types of professionals such as nurses, beneficiary attendants, physicians, residents, physiotherapists, occupational therapists, speech therapists, nutritionists, social workers, as well as people assigned to housekeeping and user transportation. If student nurses are present on these units at the time of recruitment, they may also be asked to participate.

Who may be able to join

  • adults aged 18 and over
  • employed by the SUH and working on stroke and geriatric units

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • CIUSSS de l'Estrie CHUS

    Sherbrooke, Quebec, J1H 5N4

Other trials in Canada

About this study

Official title: Acceptability of a Communication Tool Using Bedside Magnetized Posters, as Well as Barriers and Facilitators to Its Use.

The presence of appropriate systems to promote good communication within the care team is one of the ten important characteristics identified for effective interdisciplinary work. However, the current communication systems at the Eastern Townships University Health and Social Services Centre of the Sherbrooke University Hospital (SUH), an hospital setting in Sherbrooke (Quebec, Canada), are numerous, scattered and difficult to identify quickly. The bedside magnetized posters were developed to address this issue. The use of this kind of tool should improve teamwork, communication, and patient care. As the bedside magnetized posters are now well established on the stroke and geriatric units at the SUH, it is essential to evaluate their acceptability by staff members. In addition, identifying the barriers and facilitators to their use will support the team for eventual deployment in other care environments at the SUH.

Read the detailed description

The objectives of the study are:

  1. To describe the acceptability of magnetic posters by staff members in the Neurology Department - Stroke Unit, where they are already well established, and in the Geriatric Department, where they are newly introduced.
  2. To identify barriers and facilitators to the use of magnetic posters to assist the team in an eventual deployment in other care environments at SUH.

Methods

A mixed sequential design will be used (quantitative, qualitative and observational). The study population will be staff working with inpatients in the neurology-stroke and geriatric units of SUH. Staff meeting the eligibility criteria will be invited to complete an electronic survey on the acceptability of the magnetic posters. The survey will consist of 15 closed questions relating to the use of the magnetic posters (e.g. frequency of poster consultation) and its acceptability (e.g. ease of use, poster content), one open question to gather suggestions for improving the tool and 6 socio-demographic questions. The survey will take approximately 10-15 minutes to complete, and responses will be recorded on the Research Centre on Aging's RedCap server for later analysis.

Also, a member of the research team will carry out observations on the neurology-stroke and geriatric units for one half-day, in order to collect data concerning, among other things, how the posters are used (e.g. where are the posters available to staff, which posters are used) and the characteristics of the patients for whom the posters are used.

Finally, two semi-structured group interviews, one for the neurology-stroke unit and one for the geriatric unit, will be facilitated by a member of the research team. Each group will be made up of 6 to 8 employees from a variety of professions, in order to be representative of the population under study and will last 30-60 minutes. The focus groups will address the facilitators and barriers to poster use for each respective unit. Discussions will be recorded and verbatims will be kept for later analysis.

Being tested
focus group, electronic survey
Keywords
communication, multidisciplinary, hospital settings
Medical subject headings
Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • focus groupOther

    Two semi-structured group interviews, lasting 30-60 minutes, on facilitators and barriers to poster use by staff members (N=6-8).

  • electronic surveyOther

    An electronic survey of 15 closed questions on the acceptability of the magnetic posters (N=100).

Study groups in NCT05986929
Study groupRoleWhat they receive
Staff on the neurology and geriatric unitsStaff that will participate in the electronic survey (N=100) and focus group (N=6-8)
Receives: Other: focus group; Other: electronic survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability

    questions on acceptability of the magnetic posters will be asked in the electronic survey

    Measured: From the time the participants begin the electronic survey to the time their answers are sent off (approx. 15 to 20 minutes). There are no cut-off points for this outcome

  2. Barriers and facilitators

    questions on barriers and facilitators to poster use will be asked during the focus group

    Measured: This outcome will be measured during the participants' focus group, which should have a duration of approx. 60 minutes. There are no cut-off points for this outcome

Secondary outcomes (2)
  1. Questionnaire on the use of the magnetic posters

    during the observational half-day, how the posters are used (where they are used and which posters are used) in the stroke and geriatric units will be collected

    Measured: This outcome will be measured during the observational half-day, which should have a duration of approx. 4 hours. There are no cut-off points for this outcome

  2. Characteristics of the patients

    This outcome will be measured during the observational half-day, which should have a duration of approx. 4 hours.

    Measured: This outcome will be measured during the observational half-day, which should have a duration of approx. 4 hours. There are no cut-off points for this outcome

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2023
  2. Study start17 Jan 2024
  3. Primary completion5 Jul 2024
  4. Study completion5 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05986929
Sponsor's protocol ID
2024-5186
Status last verified
Apr 2024
First submitted
30 Jun 2023
Last updated
5 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Communication, Multidisciplinary, run by Université de Sherbrooke at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability (time frame: From the time the participants begin the electronic survey to the time their answers are sent off (approx. 15 to 20 minutes). There are no cut-off points for this outcome). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in